Gurugram-based, Indian health-tech platform Curelink raised USD 3.5 million in a seed funding round on March 17, 2022. Elevation Capital and Venture Highway led the financing.
The seed round also saw participation from Digital Sparrow and prominent angel investors. Vijay Shekhar Sharma of Paytm, Ankush Sachdeva and Farid Ahsan of Sharechat, Gaurav Agarwal, Prashant Tandon of Tata 1mg, Rajat K. Dhawan of McKinsey, Rohit M.A. from Cloudnine, Ritesh Malik of Innov8 and Harsh Mahajan from Mahajan Imaging, among others invested in Curelink.
Purpose of Funding for Curelink
The company intends to use the funds for the rampant hiring of professionals. They will work in operations such as products, growth, and wellness.
In addition, the health-tech startup is seeking to expand across various geographies. They are also eyeing diversification of services in different medical specialisations such as dermatology, paediatrics, and psychiatry.
Curelink seeks to reinvent chronic care management for millions of Indians in Tier-II cities and beyond.
What Curelink’s co-founder has to say
Aman Singla, the co-founder of Curelink, said –
“Today, 200 million people have non-curable diseases such as hypertension, PCOS and diabetes. Many of these people, especially those who are older or do not spend too much time on the internet, are unlikely to download a separate app to manage their health issues. They are, however, comfortable using WhatsApp to communicate with familiar medical professionals. Curelink converts vague advice, such as ‘change your diet’, to actionable advice, thereby enabling time-strapped doctors to give personalised, accurate and in-depth care to such patients, thus improving the overall quality of healthcare available to a vast number of people.”
Divyansh Jain, the co-founder of Curelink, added, “Our vision is to make healthcare convenient, both for patients as well as doctors. The tragedy of the Indian chronic care ecosystem is the lack of actionable advice that patients can refer to for managing their diseases. We enable doctors to provide support to their patients in a manner that is effortless yet exhaustive.”
What the investors have to say
“We’re excited to partner with Divyansh and Aman on their mission of delivering comprehensive, outcome driven-care to patients. Doctors are the focal point of healthcare delivery in India, and Curelink’s model of being a trusted aide to doctors resonated immediately with us. The team is hyper-focused on their stakeholders, which is amply evident in the design choices they have made: being WhatsApp-first for patients, enabling private and contextual consultations for doctors, and being squarely focused on outcomes,” said Vasudha Wadhera, Vice-President at Elevation Capital.
Samir Sood, Founding Partner, Venture Highway, said, “India needs telehealth 2.0. Chronic health conditions require ongoing supervision & management. However, due to limited bandwidth, doctors are often unable to stay updated on their patients’ progress. Curelink’s holistic approach to healthcare is empowering doctors to take a proactive approach and provide service equivalent to any digital therapeutic company. Their Whatsapp-based solution combines personal attention and AI to reimagine healthcare delivery and create better health outcomes. We resonated immediately with Divyansh and Aman’s passion, vision and product-first thinking. Moreover, we are excited to partner with the team as they build the preferred platform for Indian doctors.”
For more extensive analysis and Market Intelligence reports, feel free to approach us.
We try our best to fact-check and bring well-researched and non-plagiarized content to you. Please let us know
if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover. What information you are looking for, in the comments section below or through our contact form!
We look forward to your feedback, and thank you for stopping by!
Next Article
